The Opportunity for Our Future Health: Precision Medicine Research and Trials at Scale
Our Future Health has built three major shifts in NHS strategy are set to transform healthcare across the UK: moving care from hospitals into communities, accelerating digital transformation, and prioritising prevention over treatment. These shifts demand data-driven evidence from health and care research and trials. The UK is shifting toward inclusive, citizen-driven healthcare based on the 4Ps model—Personalised, Preventive, Predictive, and Participatory—empowering citizens to actively manage their health through tailored care, early intervention, and data-informed decisions.
Industry trials in the UK declined by 41% from 2017 to 2021 (NHS reported)
Around 86% of UK trial participants are white (NIHR)
UK’s Phase III trials global ranking plummeted from 4th to 10th in 4 years (UK Parliament)
A Scalable, Research-Embedded Digital Infrastructure
Developed in collaboration with and large funding from the US National Institutes of Health (NIH)
Real-world data driven tools used by 1,000,000 patients in the US to reduce inequalities and bridge the gap between research and care.
To meet the demands of changing needs, the UK must modernise research infrastructure – bringing health and care research studies and trials into communities and homes, thus empowering citizens through digital tools, and generating the real-world evidence needed.
These validated tools are widely used in the US and are ready for use in the UK.
✓ advance large scale cohort research and clinical trials through citizen-driven and inclusive research.
✓ align with medical research and drug development priorities through scalable, digital-first trials.
✓ reverse the decline in industry trials in the uk to unlock economic growth.
Citizen-Driven Healthcare by Meeting People Where They Are
Validated through a broad range of studies and trials and the US NIH All of Us Research Program, Vibrent’s digital platform enables research beyond clinical sites by scaling remote participation in communities and homes, community engagement, and inclusive multi-modal data collection across diverse populations. Now, these capabilities are available to the UK to help research teams expand access, ease participant burden, and accelerate insights.
How it Works
Remote and hybrid study options for low burden and expanded access
Recruitment tools and services – internet, community, site
Culturally sensitive eConsent
Integrate multimodal data sources
Real-world data: EHRs, wearables, surveys, ePROs, remote biospecimens
Automated engagement workflows for longitudinal engagement
Low-cost configuration method saves time and budget
Advanced data analytics, dashboards and visualizations
Key Data and Outcomes from the US
1.1M+ participants enrolled across diverse communities
13.6M+ surveys completed, generating rich longitudinal data
2.3M+ eConsents processed using secure digital workflows
142M+ remote engagements via SMS, mobile app, email, and post
80%+ from underrepresented groups, including rural and minority populations
1.7M+ EHR clinical data records integrated
58,000+ rural participants and 52,000+ sexual and gender minority participants
Why This Matters for the NIHR and the NHS?
The UK is under pressure to deliver faster, fairer,
and more cost-effective studies and trials. Vibrent offers a modern alternative to legacy tools like REDCap, to meet the moment.
Aligned with NHS priorities on prevention, digital transformation, and care closer to home
Enables NIHR goals for inclusion, patient-centred research, and real-world evidence generation
GDPR and MHRA compliance
Reduces burden on NHS Trusts through low-cost, scalable studies
Next Steps for NIHR and NHS
Seeking collaborations for:
Hybrid and remote decentralised studies and trials
Registries & longitudinal research expansion
Small local studies to large international drug trials
Enhancing engagement and inclusion in underrepresented communities to reduce inequalities
